Clinical Research is an integral part of oncology at Bon Secours Richmond Health System. Clinical trials give patients access to the newest and best treatments for cancer. Bon Secours Richmond Health System is proud to provide the same options as leading national cancer centers. Whether it is looking at new surgical or radiation interventions, or giving a brand new medication, We are striving to find better ways to treat, prevent, and manage cancer.
To inquire about participation in a clinical trial, please contact us at (804) 893-8717.
Please see the available, in-progress clinical trials at Bon Secours Richmond Health System. You may filter these results by searching by disease type or keyword.
Search Clinical Trials
A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with …
Receptor (EGFR) Mutant Non‐small Cell Lung Cancer (NSCLC)
A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as …
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with …
Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
A Randomized, Phase II Trial of Cabozatinib and Cabozaninib plus Nivolumab vs Standard Chemotherapy in Patients with previously treated NSCLC
A Phase III Randomized Study Comparing Perioperative Nivolumab vs Observation in Treating Patients with Renal Cell Carcinoma Undergoing Nephrectomy
NCI‐Molecular Analysis For Therapy Choice Program (NCI‐ MATCH)
What are clinical trials, and why are they important? Are there different types of cancer clinical trials? Who manages clinical …